EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy

Qinqin Jiang, David A Braun, Karl R Clauser, Vijyendra Ramesh, Nitin H Shirole, Joseph E Duke-Cohan, Nancy Nabilsi, Nicholas J Kramer, Cleo Forman, Isabelle E Lippincott, Susan Klaeger, Kshiti M Phulphagar und 34 weitere

Cell · 2025-04 · 188 (7) · 1807-1827.e34

DOI: 10.1016/j.cell.2025.01.046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2025-04. Verfasst von Qinqin Jiang und 45 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Endogenous Retroviruses, Kidney Neoplasms, Hypoxia-Inducible Factor 1, alpha Subunit. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NHLBI NIH HHS, Howard Hughes Medical Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clear cell renal cell carcinoma (ccRCC), despite having a low mutational burden, is considered immunogenic because it occasionally undergoes spontaneous regressions and often responds to immunotherapies. The signature lesion in ccRCC is inactivation of the VHL tumor suppressor gene and consequent upregulation of the HIF transcription factor. An earlier case report described a ccRCC patient who was cured by an allogeneic stem cell transplant and later found to have donor-derived T cells that recognized a ccRCC-specific peptide encoded by a HIF-responsive endogenous retrovirus (ERV), ERVE-4. We report that ERVE-4 is one of many ERVs that are induced by HIF, translated into HLA-bound peptides in ccRCCs, and capable of generating antigen-specific T cell responses. Moreover, ERV expression can be induced in non-ccRCC tumors with clinical-grade HIF stabilizers. These findings have implications for leveraging ERVs for cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellEndogenous RetrovirusesKidney NeoplasmsHypoxia-Inducible Factor 1, alpha SubunitBasic Helix-Loop-Helix ProteinsHumansImmunotherapyVon Hippel-Lindau Tumor Suppressor ProteinT-Lymphocytes

Stichwörter der Autor:innen

ERVHIFcancer vaccineccRCCimmunopeptidomicimmunotherapykidney cancerneoantigen

Substanzen

Von Hippel-Lindau Tumor Suppressor ProteinHypoxia-Inducible Factor 1, alpha SubunitBasic Helix-Loop-Helix ProteinsVHL protein, human

Autor:innen und Institutionen

  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Yale Center of Cellular and Molecular Oncology, Yale School of Medicine, New Haven, CT 06511, USA.
  • Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA.
  • Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • TScan Therapeutics, Waltham, MA 02451, USA.
  • Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02215, USA.

Förderung

  • NCI NIH HHS
  • NHLBI NIH HHS
  • Howard Hughes Medical Institute
  • NIGMS NIH HHS
  • US Department of Defense
  • National Institutes of Health
  • National Institutes of Health National Cancer Institute
  • Breast Cancer Research Foundation

Zitieren

APA

Jiang, Q., Braun, D. A., Clauser, K. R., Ramesh, V., Shirole, N. H., Duke-Cohan, J. E., Nabilsi, N., Kramer, N. J., Forman, C., Lippincott, I. E., Klaeger, S., Phulphagar, K. M., Chea, V., Kim, N., Vanasse, A. P., Saad, E., Parsons, T., Carr-Reynolds, M., Carulli, I., …, & Kaelin, W. G. (2025). HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy. Cell, 188(7), 1807-1827.e34. https://doi.org/10.1016/j.cell.2025.01.046

Vancouver

Jiang Q, Braun DA, Clauser KR, Ramesh V, Shirole NH, Duke-Cohan JE, et al. HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy. Cell. 2025;188(7):1807-1827.e34. doi:10.1016/j.cell.2025.01.046

BibTeX
@article{Jiang2025,
  author = {Jiang, Qinqin and Braun, David A and Clauser, Karl R and Ramesh, Vijyendra and Shirole, Nitin H and Duke-Cohan, Joseph E and Nabilsi, Nancy and Kramer, Nicholas J and Forman, Cleo and Lippincott, Isabelle E and Klaeger, Susan and Phulphagar, Kshiti M and Chea, Vipheaviny and Kim, Nawoo and Vanasse, Allison P and Saad, Eddy and Parsons, Teagan and Carr-Reynolds, Melissa and Carulli, Isabel and Pinjusic, Katarina and Jiang, Yijia and Li, Rong and Syamala, Sudeepa and Rachimi, Suzanna and Verzani, Eva K and Stevens, Jonathan D and Lane, William J and Camp, Sabrina Y and Meli, Kevin and Pappalardi, Melissa B and Herbert, Zachary T and Qiu, Xintao and Cejas, Paloma and Long, Henry W and Shukla, Sachet A and Van Allen, Eliezer M and Choueiri, Toni K and Churchman, L Stirling and Abelin, Jennifer G and Gurer, Cagan and MacBeath, Gavin and Childs, Richard W and Carr, Steven A and Keskin, Derin B and Wu, Catherine J and Kaelin, William G},
  title = {HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy},
  journal = {Cell},
  year = {2025},
  volume = {188},
  number = {7},
  pages = {1807--1827.e34},
  doi = {10.1016/j.cell.2025.01.046}
}
Kostenlos starten →